no image available Dickens & Co. "Marking a Turning Point: The Promise of Dotatate in Combatting Aggressive Gastroenteropancreatic Neuroendocrine Tumors" "A Phase II Study Unlocks the Potential of Radionuclide Treatment in Progressive Metastatic Cases" Price: 24.00€